Skip to main navigation Skip to search Skip to main content

Severe and fatal COVID-19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes

  • Olga Bloch*
  • , Perl Kobi
  • , Ariel Ben Shimol
  • , Assaf Rotmensh
  • , Dana Kagansky
  • , Dana Zelnik-Yovel
  • , Gilad Ben Yehudah
  • , Dror Cantrell
  • , Micha J. Rapoport
    • *Corresponding author for this work
  • Assaf Harofeh Medical Center

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Severe and fatal COVID-19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology